G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges

Full article: GPR119 agonists for the treatment of type 2 diabetes: an updated patent review (2014-present)

GPR119 Agonists: A Novel Strategy for Type 2 Diabetes Treatment

G protein-coupled receptors for energy metabolites as new therapeutic targets

Deciphering G-Protein-Coupled Receptor 119 Agonists as Promising Strategy against Type 2 Diabetes Using Systems Biology Approach

GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus - ScienceDirect

Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. - Abstract - Europe PMC

Deciphering G-Protein-Coupled Receptor 119 Agonists as Promising Strategy against Type 2 Diabetes Using Systems Biology Approach

Design of Potent and Orally Active GPR119 Agonists for the Treatment of Type II Diabetes. - Abstract - Europe PMC

G Protein-Coupled Receptor 119 (GPR119) Agonists for the Treatment of Diabetes: Recent Progress and Prevailing Challenges

Frontiers Structure of human GPR119-Gs complex binding APD597 and characterization of GPR119 binding agonists

Regulation of GPR119 receptor activity with endocannabinoid-like lipids